TH027
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TH027, covering 2025-05-13 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors [EARLY_Phase 1]